1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players

Summary

GlobalData has released its pharma report, “PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Prophylactic hepatitis B virus vaccines Market. The report identifies and analyses the key companies shaping and driving the global prophylactic hepatitis B virus vaccines market. The report provides insight into the competitive prophylactic hepatitis B virus vaccines landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

- Investigation of current and future market competition for prophylactic hepatitis B virus vaccines
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of prophylactic hepatitis B virus vaccines sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving prophylactic hepatitis B virus vaccines market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What’s the next big thing in the global prophylactic hepatitis B virus vaccines market landscape? Identify, understand and capitalize

Table Of Contents

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players
1 Table of Contents

2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Related Reports 12
3 Market Outlook 13
3.1 Global Markets 13
3.1.1 Forecast 13
3.1.2 Drivers and Barriers - Global Issues 17
4 Current and Future Players 24
4.1 Overview 24
4.2 Trends in Corporate Strategy 28
4.3 Company Profiles 30
4.3.1 GSK 30
4.3.2 Merck 34
4.3.3 Sanofi 36
4.3.4 Kaketsuken 39
4.3.5 Dynavax Technologies 40
5 Appendix 43
5.1 Bibliography 43
5.2 Abbreviations 55
5.3 Methodology 57
5.4 Forecasting Methodology 57
5.4.1 Patient Populations Targeted for Vaccination 58
5.4.2 Vaccination Coverage Rates 61
5.4.3 Vaccinated Patients 62
5.4.4 Regulatory Approval vs. Advisory Committee Recommendation 62
5.4.5 General Pricing Assumptions 63
5.5 Physicians and Specialists Included in this Study 64
5.5.1 Interviews of Key Opinion Leaders (KOLs) 64
5.5.2 Online Survey of High-Prescribing Physicians (non-KOLs) 66
5.6 About the Authors 67
5.6.1 Analyst 67
5.6.2 Therapy Area Director 67
5.6.3 Global Head of Healthcare 68
5.7 About GlobalData 69
5.8 Disclaimer 69

1.1 List of Tables

Table 1: Global Sales Forecasts ($m) for HBV Vaccines, 2012-2022 15
Table 2: Global HBV Vaccine Market - Drivers and Barriers, 2014 17
Table 3: Key Companies in the HBV Vaccine Market, 2014 26
Table 4: GSK's HBV Vaccine Portfolio Assessment, 2014 32
Table 5: GSK SWOT Analysis, 2014 33
Table 6: Merck's HBV Vaccine Portfolio Assessment, 2014 35
Table 7: Merck SWOT Analysis, 2014 36
Table 8: Sanofi's HBV Vaccine Portfolio Assessment, 2014 38
Table 9: Sanofi SWOT Analysis, 2014 38
Table 10: Kaketsuken's HBV Vaccine Portfolio Assessment, 2014 39
Table 11: Kaketsuken SWOT Analysis, 2014 40
Table 12: Dynavax Technologies' HBV Vaccine Portfolio Assessment, 2014 41
Table 13: Dynavax Technologies SWOT Analysis, 2014 42
Table 14: Patient Population(s) Targeted for HBV Vaccination in the Pediatric Market, by Country 59
Table 15: Patient Population(s) Targeted for HBV Vaccination in the Adult Market, by Country 60
Table 16: High-Prescribing Physicians (non-KOLs) Surveyed, by Country 66

1.2 List of Figures

Figure 1: Global Sales for HBV Vaccines by Country, 2012-2022 16
Figure 2: Global Sales for HBV Vaccines by Company, 2012-2022 27
Figure 3: Company Portfolio Gap Analysis in HBV Vaccines, 2012-2022 28

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025 Summary Hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic infections ...

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations Summary Hepatitis C is a blood-borne viral infection ...

2017-2021 Hepatitis Diagnostic Testing Market

2017-2021 Hepatitis Diagnostic Testing Market

  • $ 6250
  • Industry report
  • February 2017
  • by Venture Planning Group

The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.